FFCP PHASE1:Mm9::chr10:111433815..111433856,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=6|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr10:111433815..111433856,+|id=chr10:111433815..111433856,+|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=CL:0000355,1.79e-09,9;CL:0000049,1.12e-07,19|ontology_enrichment_disease=DOID:0060100!3.66e-16!3;DOID:4045!3.66e-16!3;DOID:0050686!2.47e-08!6|ontology_enrichment_disease_v019_2=DOID:0060100,4.66e-27,3;DOID:4045,4.66e-27,3;DOID:0050686,6.75e-14,6|ontology_enrichment_uberon=|ontology_enrichment_uberon_v019_2=UBERON:0001134,1.79e-09,9;UBERON:0002036,1.79e-09,9;UBERON:0002385,1.79e-09,9;UBERON:0000486,1.79e-09,9;UBERON:0007503,1.79e-09,9;UBERON:0001015,1.79e-09,9;UBERON:0002329,1.79e-09,9;UBERON:0003082,1.79e-09,9;UBERON:0003059,1.79e-09,9;UBERON:0007282,1.79e-09,9;UBERON:0004290,1.79e-09,9;UBERON:0009618,1.79e-09,9;UBERON:0000383,1.39e-08,10;UBERON:0007524,7.44e-08,11;UBERON:0003077,7.44e-08,11;UBERON:0007285,7.44e-08,11;UBERON:0002204,6.69e-07,32|phase1_expression=0,0,0,0,0,0,0,0.129123323441576,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.4409111995798,1.5626706890476,1.57057123192139,33.5291948177678,0.683045484958446,2.42755176515577,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.718890747035522,1.79970819298022,2.1601938602421,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.54408744268829,1.13665399758237,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0701358198903186,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.679913719975421,0.839708713941948,1.10559979043539,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.19318959403219,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.231867835620421|short_description=p@chr10:111433815..111433856,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=6 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr10:111433815..111433856,+ | |||
|description=CAGE_peak_at_chr10:111433815..111433856,+ | |||
|id=chr10:111433815..111433856,+ | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2=CL:0000355,1.79e-09,9;CL:0000049,1.12e-07,19 | |||
|ontology_enrichment_disease=DOID:0060100!3.66e-16!3;DOID:4045!3.66e-16!3;DOID:0050686!2.47e-08!6 | |||
|ontology_enrichment_disease_v019_2=DOID:0060100,4.66e-27,3;DOID:4045,4.66e-27,3;DOID:0050686,6.75e-14,6 | |||
|ontology_enrichment_uberon= | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001134,1.79e-09,9;UBERON:0002036,1.79e-09,9;UBERON:0002385,1.79e-09,9;UBERON:0000486,1.79e-09,9;UBERON:0007503,1.79e-09,9;UBERON:0001015,1.79e-09,9;UBERON:0002329,1.79e-09,9;UBERON:0003082,1.79e-09,9;UBERON:0003059,1.79e-09,9;UBERON:0007282,1.79e-09,9;UBERON:0004290,1.79e-09,9;UBERON:0009618,1.79e-09,9;UBERON:0000383,1.39e-08,10;UBERON:0007524,7.44e-08,11;UBERON:0003077,7.44e-08,11;UBERON:0007285,7.44e-08,11;UBERON:0002204,6.69e-07,32 | |||
|phase1_expression=0,0,0,0,0,0,0,0.129123323441576,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.4409111995798,1.5626706890476,1.57057123192139,33.5291948177678,0.683045484958446,2.42755176515577,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.718890747035522,1.79970819298022,2.1601938602421,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.54408744268829,1.13665399758237,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0701358198903186,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.679913719975421,0.839708713941948,1.10559979043539,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.19318959403219,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.231867835620421 | |||
|short_description=p@chr10:111433815..111433856,+ | |||
}} |
Latest revision as of 21:12, 3 August 2015
Short description: | p@chr10:111433815..111433856, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr10:111433815..111433856, + |
Coexpression cluster: | MCL_coexpression_mm9:6 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
multi-potent skeletal muscle stem cell | 1.79e-09 | 9 |
common myeloid progenitor | 1.12e-07 | 19 |
Ontology term | p-value | n |
---|---|---|
skeletal muscle tissue | 1.79e-09 | 9 |
striated muscle tissue | 1.79e-09 | 9 |
muscle tissue | 1.79e-09 | 9 |
multilaminar epithelium | 1.79e-09 | 9 |
epithelial vesicle | 1.79e-09 | 9 |
musculature | 1.79e-09 | 9 |
somite | 1.79e-09 | 9 |
myotome | 1.79e-09 | 9 |
presomitic mesoderm | 1.79e-09 | 9 |
presumptive segmental plate | 1.79e-09 | 9 |
dermomyotome | 1.79e-09 | 9 |
trunk paraxial mesoderm | 1.79e-09 | 9 |
musculature of body | 1.39e-08 | 10 |
dense mesenchyme tissue | 7.44e-08 | 11 |
paraxial mesoderm | 7.44e-08 | 11 |
presumptive paraxial mesoderm | 7.44e-08 | 11 |
musculoskeletal system | 6.69e-07 | 32 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 4.66e-27 | 3 |
muscle cancer | 4.66e-27 | 3 |
organ system cancer | 6.75e-14 | 6 |